Steven M Brunelli
Overview
Explore the profile of Steven M Brunelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
3219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratkalkar V, Marlowe G, Sibbel S, Tentori F, Brunelli S, Karpinski S
Hemodial Int
. 2025 Jan;
PMID: 39888257
Introduction: Chronic kidney disease-mineral and bone disorder (CKD-MBD), is a common syndrome in end stage kidney disease (ESKD) patients, is marked by dysregulation of electrolytes and hormones, including calcium, phosphorus...
2.
Karpinski S, Sibbel S, Gray K, Walker A, Luo J, Colson C, et al.
Am J Manag Care
. 2023 Sep;
29(9):e262-e266.
PMID: 37729531
Objectives: Patients with chronic kidney disease (CKD) are at higher risk of being admitted to the hospital than the general population. Hospitalizations in patients with CKD are associated with higher...
3.
Naljayan M, Hunt A, McKeon K, Marlowe G, Schreiber M, Brunelli S, et al.
J Nephrol
. 2023 Aug;
36(7):1897-1905.
PMID: 37644364
Background: Incremental peritoneal dialysis (PD) can be defined as a PD prescription that is less than the standard, full dose prescription and is typically used for patients initiating PD with...
4.
5.
Lo R, Kalantar-Zadeh K, You A, Ayus J, Streja E, Park C, et al.
Clin Kidney J
. 2022 Nov;
15(12):2322-2330.
PMID: 36381361
Background: Emerging data suggest that sodium disarrays including hyponatremia are potential risk factors for infection ensuing from impairments in host immunity, which may be exacerbated by coexisting conditions (i.e. mucosal...
6.
McKeon K, Sibbel S, Brunelli S, Matheson E, Lefeber N, Epps M, et al.
Kidney Med
. 2022 Jul;
4(7):100490.
PMID: 35801188
Rationale & Objective: Treatment options for kidney failure are complex, and the majority of patients transitioning to dialysis lack important information about treatment options and are not prepared to make...
7.
Karpinski S, Sibbel S, Cohen D, Colson C, Van Wyck D, Ghaffari A, et al.
Perit Dial Int
. 2022 Mar;
43(2):186-189.
PMID: 35272530
The majority of end-stage kidney disease (ESKD) patients start dialysis without adequate pre-dialysis planning. Of these patients, the vast majority initiate in-centre haemodialysis using a central venous catheter (ICHD-CVC). A...
8.
Brunelli S, Sibbel S, Karpinski S, Marlowe G, Walker A, Giullian J, et al.
J Am Soc Nephrol
. 2022 Feb;
33(4):688-697.
PMID: 35135894
Background: Studies have demonstrated that mRNA-based SARS-CoV-2 vaccines are highly effective among patients on dialysis. Because individual vaccines may be differentially available or acceptable to patients, it is important to...
9.
Sibbel S, McKeon K, Luo J, Wendt K, Walker A, Kelley T, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):49-57.
PMID: 34789546
Background: Patients on hemodialysis have an elevated risk for COVID-19 but were not included in efficacy trials of SARS-CoV-2 vaccines. Methods: We conducted a retrospective, observational study to estimate the...
10.
Cohen D, Sibbel S, Marlowe G, Bludorn K, Miller D, Kelley T, et al.
J Am Soc Nephrol
. 2021 Jul;
32(8):1880-1886.
PMID: 34215666
Background: Although reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rare among individuals with few coronavirus disease 2019 (COVID-19) risk factors, the ability of naturally acquired immunity to...